Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8 PF-07321332 Boceprevir Phakathi
Ubonelelo ngezoRhwebo PF-07321332 Paxlovid abaPhakathi abaNxungupheleyo abanoMgangatho oPhezulu
I-L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
I-Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
I-Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Igama leMchiza | IMethyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate |
Izithethantonye | I-Methyl (S) -2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate;(αS,3S) -α-[(tert-Butyloxycarbonyl)aMino]-2-oxo-3-pyrrolidinepropanoic acid iMethyl Ester;(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate |
Inombolo yeCAS | 328086-60-8 |
Inombolo yeCAT | RF-PI317 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | I-C13H22N2O5 |
Ubunzima beMolekyuli | 286.33 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kwi-Off-White Powder |
Isazisi A | I-IR: Ifana neNgcaciso yeNgcaciso |
Isazisi B | Ixesha lokuGcina: Liyafana neNxibelelwano yeSiza |
Ilahleko ekomisweni | ≤1.0% |
Intsalela kwi-Ignition | ≤0.20% |
Ukungacoceki Okukodwa | ≤0.50% |
Ukungcola ngokupheleleyo | ≤2.0% |
Iintsimbi ezinzima (Pb) | ≤20ppm |
Ubunyulu | ≥98.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Phakathi kwe-PF-07321332 Paxlovid (CAS 2628280-40-8) kunye ne-Boceprevir (CAS 394730-60-0) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Methyl (S)-2- (Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate (CAS 328086-60-8) yindawo ephakathi ye-PF-07321332 Paxlovid (CAS 2628280-40) -8) kunye ne-Boceprevir (CAS 394730-60-0).PF-07321332, icandelo eliphambili le-Paxlovid (PF-07321332 kunye ne-Ritonavir) engumgqatswa we-COVID-19 oral antiviral, yi-3C-like protease inhibitor efumanekayo ngomlomo (3CLPRO) eneziphumo ezinamandla zokulwa nentsholongwane ye-SARS-CoV-2 kunye ne-COVID-19.Ngomhla we-6 kaNove ngo-2021, uPfizer wabhengeza ukuba uPaxlovid unciphise kakhulu ukulaliswa esibhedlele kunye nokufa, ngokusekwe kuhlalutyo lwethutyana lweSigaba 2/3 se-EPIC-HR (Vavaluation of Protease Inhibition for COVID-19 in High-Risk Patients) uphando olungacwangciswanga, oluyimfama kabini. yabaguli abangalaliswanga esibhedlele abane-COVID-19, abasengozini enkulu yokuqhubekela phambili kwisigulo esiqatha.I-Boceprevir (EBP-520) yi-HCV protease inhibitor (Ki=14 nM) kunyango lwentsholongwane ye-hepatitis C.I-Boceprevir ene-pegylated interferon kunye ne-ribavirin (i-PegIFN / RBV) yenza ukuphuculwa kwemilinganiselo eqhubekayo ye-virological impendulo yezigulane ezine-genotype 1 HCV.I-Boceprevir isebenzisana ne-immunosuppressive therapy (IT) ngokuvimbela i-cytochrome P450 3A enzyme.